Show simple item record

dc.contributor.authorSingh, Nisha
dc.contributor.authorMcMahon, Hannah
dc.contributor.authorBilderbeck, Amy
dc.contributor.authorReed, Zoe E
dc.contributor.authorTunbridge, Elizabeth
dc.contributor.authorBrett, Daniel
dc.contributor.authorGeddes, John R
dc.contributor.authorGoodwin, Guy M
dc.date.accessioned2018-10-22T14:25:06Z
dc.date.available2018-10-22T14:25:06Z
dc.date.issued2018-03
dc.identifier.citationSingh, Nisha; McMahon, Hannah; Bilderbeck, Amy; Reed, Zoe E; Tunbridge, Elizabeth; Brett, Daniel; Geddes, John R; Churchill, Grant C; Goodwin, Guy M. Plasma glutathione suggests oxidative stress is equally present in early- and late- onset bipolar disorder. Bipolar Disorders. 2018;1–7.en
dc.identifier.issn1399-5618
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/105
dc.description.abstractWe previously demonstrated oxidative stress in bipolar patients and a relationship between the age of illness onset and total glutathione, a principal antioxi- dant. In this study, we sought to replicate these findings in a new cohort of patients. Methods: We recruited bipolar patients from Warneford Hospital, Oxford, UK, of similar age and grouped them according to age of onset of illness. The early- onset group comprised patients with onset at <23 years, and the late group comprised pa- tients with onset at >30 years. A third group, comprising age- matched healthy volun- teers, was also included. Reduced and oxidized glutathione, cysteine, and cystine were determined in plasma, using high- performance liquid chromatography. Mitochondrial DNA copy number, measured in whole blood, was also compared be- tween patients and healthy controls. Results: Significant increases in oxidative stress were observed in the patient groups, compared with the control group; however, no differences in glutathione- related oxi- dative stress measures were detected between the early- and late- onset bipolar pa- tient groups. No differences were observed in the amount of mitochondrial DNA, and there was no correlation with mood state. Conclusion: Using a more accurate method to quantify oxidative stress than in our previous study, we show that oxidative stress is a consistent feature of bipolar disor- der. Although we did not reproduce our finding correlating age of onset of illness to oxidative stress, we have shown, once again, that oxidative stress is a consistent fea- ture of bipolar disorderen
dc.description.sponsorshipThis paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Reference Number RP- PG- 0108- 10087). ACB was supported by a Wellcome Trust Strategic Award (CONBRIO: Collaborative Oxford Network for Bipolar Research to Improve Outcomes, Reference number 102616/Z). GMG and JG are NIHR Senior Investigators. GMG holds a grant from the Wellcome Trust. GMG has shares in P1vital and has served as a consultant, advisor or CME speaker for Allergan, Angelini, Compass pathways, MSD, Lundbeck (/Otsuka or Takeda), Medscape, P1Vital, Pfizer, Servier, Shire, and Sun Pharma. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.en
dc.description.urihttps://doi.org/10.1111/bdi.12640
dc.language.isoenen
dc.subjectBipolar Disorderen
dc.titlePlasma glutathione suggests oxidative stress is equally present in early- and late- onset bipolar disorderen
dc.typeArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record